Myocarditis Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Myocarditis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION

Heart FailureLong COVID SyndromeMyocarditis+2 more
Johann Wolfgang Goethe University Hospital6,000 enrolled1 locationNCT04444128
Recruiting

Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition

Hypertrophic CardiomyopathyMyocarditisHeart Failure With Preserved Ejection Fraction+4 more
University of Edinburgh290 enrolled1 locationNCT06409585
Recruiting
Phase 3

MYTHS - MYocarditis THerapy With Steroids

Myocarditis Acute
Niguarda Hospital288 enrolled49 locationsNCT05150704
Recruiting

Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer

Lung CancerMyocarditis Due to Drug
Shanghai Chest Hospital50 enrolled1 locationNCT06818149
Recruiting
Phase 3

CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine

Heart FailureCardiomyopathiesMyocarditis+2 more
Niguarda Hospital80 enrolled10 locationsNCT06158698
Recruiting

Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics

CardiomyopathiesBrain NeoplasmsHypertension+9 more
First Affiliated Hospital Xi'an Jiaotong University25,000 enrolled1 locationNCT06001073
Recruiting
Phase 4

Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.

Heart FailureMyocarditisImmunosuppression+2 more
Medical University of Warsaw100 enrolled1 locationNCT04654988
Recruiting
Not Applicable

Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine

CancerAlzheimer DiseaseMyocarditis+1 more
Central Hospital, Nancy, France100 enrolled1 locationNCT06116084
Recruiting
Phase 4

Clinical Study of Endocardial Myocardial Biopsy

Heart FailureCardiomyopathiesMyocarditis+2 more
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT05718128
Recruiting

Global Cardio Oncology Registry

Breast CancerCardiotoxicityCardiovascular Diseases+2 more
The Cleveland Clinic5,000 enrolled1 locationNCT05598879